FDA has removed certain bulk drug substances that were placed on the category two list and has announced it will consult the Pharmacy Compounding Advisory Committee (PCAC) for potential future inclusion of FDA Peptide Category Update: Clarifying Misinformation Cole Thomas posted on the topic LinkedIn FDA July 2026 Peptide Meeting: What Patients Need to Know About Access, Approval, and Safety Meto blog When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion